CRISPR/cas9 genome editing is used to introduce a G to A mutation resulting in an arginine to a histidine missense mutation (R140H) in the first coding exon (exon 2). The mutation is homologous to one found in pontocerebellar hypoplasia type 10 (PCH10) patients. (J:310471)